Open AccessUpdate on afatinib-based combination regimens for the treatment of EGFR mutation-positive non-small-cell lung cancer
Author(s) -
Jaafar Bennouna
Publication year - 2017
Publication title -
future oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.857
H-Index - 72
eISSN - 1744-8301
pISSN - 1479-6694
DOI - 10.2217/fon-2017-0240
Subject(s) - afatinib , erlotinib , gefitinib , medicine , lung cancer , oncology , t790m , epidermal growth factor receptor , erbb3 , cancer research , cancer
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom